---
pmcid: PMC8020387
image_filename: ol-21-05-12671-g04.jpg
figure_link: /pmc/articles/PMC8020387/figure/f5-ol-0-0-12671/
number: Figure 5
figure_title: ''
caption: KEGG enrichment analysis and expression levels of PIK3CA, AKT1 and MTOR.
  (A) KEGG pathway enrichment analysis of the green module. (B) Gene expression levels
  of PIK3CA, AKT1 and MTOR based on CENPA expression in the PCR and RD groups in the
  Gene Expression Omnibus data. (C) Gene expression levels of PIK3CA, AKT1 and MTOR
  based on CENPA expression in the CCR and RD groups in data from The Cancer Genome
  Atlas. KEGG, Kyoto Encyclopedia of Genes and Genomes; PIK3CA, PI3K catalytic subunit
  Î±; CENPA, centromere protein A; PCR, pathological complete response; RD, residual
  disease; CCR, clinical complete response.
article_title: High expression levels of centromere protein A plus upregulation of
  the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway
  affect chemotherapy response and prognosis in patients with breast cancer.
citation: Songbo Zhang, et al. Oncol Lett. 2021 May;21(5):410.

doi: 10.3892/ol.2021.12671
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos

keywords:
- breast cancer
- centromere protein A
- neoadjuvant chemotherapy
- phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway
- residual disease

---
